Prolonged Central Nervous System Response in a Patient With <i>HER2</i> Mutant NSCLC Treated With First-Line Poziotinib.

Tchekmedyian, Nishan; Paxton, Bill; Lebel, Francois; Keossayan, Lena; Heymach, John V

Prolonged Central Nervous System Response in a Patient With HER2 Mutant NSCLC Treated With First-Line Poziotinib.

Tchekmedyian, Nishan; Paxton, Bill; Lebel, Francois; Keossayan, Lena; Heymach, John V.

Afiliação

Tchekmedyian N; Pacific Shores Medical Group, Huntington Beach, California.
Paxton B; Spectrum Pharmaceuticals, Irvine, California.
Lebel F; Spectrum Pharmaceuticals, Irvine, California.
Keossayan L; Pacific Shores Medical Group, Huntington Beach, California.
Heymach JV; Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

JTO Clin Res Rep ; 1(4): 100081, 2020 Nov.

Article em En | MEDLINE | ID: mdl-34589960

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: JTO Clin Res Rep Ano de publicação: 2020 Tipo de documento: Article